antithrombotic therapy

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)

The observed thrombosis rate of 2.8% in pregnant Fontan patients on various antithrombotic regimens was not higher than the 4-33% rate reported outside pregnancy in this population, suggesting current

Effect: improvement; 2.8% thrombosis rate (3/108 pregnancies)